Apoptosis
Btk
|
Product name : ABT-869 (Linifanib, AL 39324)
Item : cc204
Price : 200mg, $950;500mg, $1595; 1g $2390; 2g, $3590
contact : Send inquiry to: info@acesobio.com,or by fax to: 1-845-673-1239.
CAS : 796967-16-3
Molecular Weight : 375.4
Formula : C₂₁H₁₈FN₅O
Storage : at -20°C
Additional information : We offer significant discount for bulky quantity order
 |
| Details: | |||||||||||||||||||||||||
ABT-869 (Linifanib) is a novel, potent ATP-competitive RTK inhibitor of KDR, CSF-1R, Flt1 and Flt3 with IC50 of 4 nM, 3 nM, 3 nM and 3 nM, respectively. ABT869 inhibits members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases. ABT 869 does not have a general antiproliferative effect due to its high dose requirement. However, linifanib may exhibit potent antiproliferative and apoptotic effects on tumor cells whose proliferation is dependent on mutant kinases, such as fms-related tyrosine kinase receptor-3 (FLT3). [1][2]
Reference:
[1] Mol. Cancer Ther. 2006, 5, 995-1006.
[2] Mol. Cancer Ther. 2006, 5, 1007-1013.
Chemical Information
PLEASE KEEP THE PRODUCT UNDER -20℃ FOR LONG-TERM STORAGE.
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.
|
| Related Products : |
|
|
|
|
||||||||
|
|
|
|
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian